Examples of Positions Filled

  • Independent Board Searches:
    • Rob Chess joins Board of CoTherix, Inc.
    • Jean-Jacques Bienaime joins Board of Saegis Pharmaceuticals, Inc.
    • Harry Hixson and Dan Kisner join Board of SEQUENOM
  • President & Chief Executive Officer:
    • Barry Wolitsky, Ph.D. joins The Immune Tolerance Network as COO
    • Joseph Vallner, Ph.D. joins Capnia, Inc.
    • Alan Lewis, Ph.D. Joins Novocell, Inc.
    • William Rice, Ph.D. joins Cylene Pharmaceuticals, Inc.
    • Christine Meda joins Diamics, Inc. as President
  • Business Development Positions:
    • Bruce Steel joins Anaphore, Inc. as Chief Business Officer
    • Barry Toyonaga, Ph.D. joins Traversa Therapeutics, Inc. as SVP, Business Development
    • Stephen J. Hurst, J.D. as Chief Business Officer of The Immune Tolerance Institute, Inc.
    • Marty Emanuele, Ph.D. to Kemia, Inc. as SVP, Business Development
    • Jack Anthony to Saegis Pharmaceuticals as SVP, Business Development
    • Peter Amatulli joins Gentiae Clinical Research as V.P. of Commercial Development
    • David Pritchard to RINAT Neuroscience as CBO
    • Peter Fuller to Cellular Genomics as CBO
    • Chris Burnley to Phenomix as CBO
    • David Slack to Sequenom as Business Consultant
    • Bill Daly to CHIRON as Sr. Director of Corporate Mergers & Acquisitions
  • Product Development/Chief Medical Officer:
    • Stanford Lee-Yu Peng, M.D./Ph.D. to ARYx Therapeutics, Inc. as Sr. Director, Medical Affairs
    • Dale Ando, M.D. to Sangamo BioSciences as V.P. Product Development & CMO
  • Operations:
    • Jean Amos Wilson, Ph.D. to SEQUENOM, Inc. as Sr. Director Genetic Services
    • Cy Cabradilla, Ph.D. to EPOCH Biosciences as V.P. Operations
  • Research & Development:
    • Aaron Kantor, Ph.D. as Chief Scientific Officer of The Immune Tolerance Institute, Inc.
    • Daniel Levitt, M.D., Ph.D. joins Cerimon Pharmaceuticals, Inc. as EVP, Research & Development
    • Elizabeth Dragon, Ph.D. joins SEQUENOM, Inc. as EVP, Research & Development
    • John Nestor, Ph.D. to SEQUENOM Pharmaceuticals Div. as EVP, Drug Discovery
    • Bill Moore, Ph.D. to Locus Pharmaceuticals as Chief Scientific Officer
    • Xiaoming Zhang, Ph.D. to Athenagen, Inc. as Senior Director, Chemistry
  • Regulatory Affairs/Quality Assurance
    • Richard Reeves to Varian Oncology Medical Systems as Vice President, RA/QA
    • Robert Di Tullio, to SEQUENOM, Inc. as V.P. Regulatory Affairs, Quality & Clinical Affairs
  • CFO/Finance
    • Vince Barella to Trellis Bioscience as Sr. Director Finance and Controller
    • C. Fletcher Payne to CytomX as CFO/Consultant